| 000 | 01741 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516234906.0 | ||
| 264 | 0 | _c20151105 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1348-4214 | ||
| 024 | 7 |
_a10.1038/hr.2014.148 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Jie | |
| 245 | 0 | 0 |
_aPrevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. _h[electronic resource] |
| 260 |
_bHypertension research : official journal of the Japanese Society of Hypertension _cFeb 2015 |
||
| 300 |
_a123-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aBenzoates _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aIndapamide _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Diseases _xetiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 | _aTelmisartan |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZhao, Yingxin | |
| 700 | 1 | _aZhang, Hua | |
| 700 | 1 | _aLiu, Zhendong | |
| 700 | 1 | _aWang, Zhihao | |
| 700 | 1 | _aTang, Mengxiong | |
| 700 | 1 | _aZhong, Ming | |
| 700 | 1 | _aLu, Fanghong | |
| 700 | 1 | _aZhang, Wei | |
| 773 | 0 |
_tHypertension research : official journal of the Japanese Society of Hypertension _gvol. 38 _gno. 2 _gp. 123-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/hr.2014.148 _zAvailable from publisher's website |
| 999 |
_c24239433 _d24239433 |
||